Marginum is developing fluorescence-based tissue detection systems.
Marginum has raised €2.5M across 1 funding round from 3 investors, most recently a Seed round in Aug 2025. Based in Kuopio, Finland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-08-25 | Seed | €2.5M |
| Almaral,Nostetta Ventures,Redstone |
| View deal → |
